Back
NeuroBo Pharmaceuticals Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
26
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.41
Seasonality Move:
-8.74%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing slight buying pressure.
NeuroBo Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.63 | Sell |
| 20-day SMA: | 2.74 | Sell |
| 50-day SMA: | 2.99 | Sell |
| 200-day SMA: | 3.92 | Sell |
| 8-day EMA: | 2.64 | Sell |
| 20-day EMA: | 2.71 | Sell |
| 50-day EMA: | 2.97 | Sell |
| 200-day EMA: | 4.87 | Sell |
NeuroBo Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 41.5 | Sell |
| Chaikin Money Flow: | 15242 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.54 - 2.86) | Sell |
| Bollinger Bands (100): | (2.83 - 4.27) | Sell |
NeuroBo Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NeuroBo Pharmaceuticals Stock
Is NeuroBo Pharmaceuticals Stock a Buy?
- NeuroBo Pharmaceuticals share price is 2.56 while NRBO 8-day simple moving average is 2.63, which is a Sell signal.
- The stock price of NRBO is 2.56 while NeuroBo Pharmaceuticals 20-day SMA is 2.74, which makes it a Sell.
- NeuroBo Pharmaceuticals 50-day simple moving average is 2.99 while NRBO share price is 2.56, making it a Sell technically.
- NRBO stock price is 2.56 and NeuroBo Pharmaceuticals 200-day simple moving average is 3.92, creating a Sell signal.
NRBO Technical Analysis vs Fundamental Analysis
Sell
26
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy or a Sell?
-
NeuroBo Pharmaceuticals stock is rated a Sell
The current NeuroBo Pharmaceuticals [NRBO] share price is $2.56. The Score for NRBO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
NeuroBo Pharmaceuticals Stock Info
Market Cap:
21.73M
Price in USD:
2.56
Share Volume:
67.5K
NeuroBo Pharmaceuticals 52-Week Range
52-Week High:
6.75
52-Week Low:
2.08
Sell
26
NeuroBo Pharmaceuticals (NRBO)
is a Sell
NeuroBo Pharmaceuticals Share Price Forecast
-
What is the NeuroBo Pharmaceuticals stock price today?
The NeuroBo Pharmaceuticals stock price is 2.56 USD today. -
Will NRBO stock go up or go down?
NeuroBo Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NeuroBo Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NeuroBo Pharmaceuticals is overvalued.
Is NeuroBo Pharmaceuticals Stock a Buy?
- NeuroBo Pharmaceuticals share price is 2.56 while NRBO 8-day exponential moving average is 2.64, which is a Sell signal.
- The stock price of NRBO is 2.56 while NeuroBo Pharmaceuticals 20-day EMA is 2.71, which makes it a Sell.
- NeuroBo Pharmaceuticals 50-day exponential moving average is 2.97 while NRBO share price is 2.56, making it a Sell technically.
- NRBO stock price is 2.56 and NeuroBo Pharmaceuticals 200-day simple moving average is 4.87, creating a Sell signal.
Technical Analysis of NeuroBo Pharmaceuticals
Should I short NeuroBo Pharmaceuticals stock?
- NRBO Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting NeuroBo Pharmaceuticals is a Sell
- NeuroBo Pharmaceuticals Relative Strength Index (RSI) is 41.5, which suggest NeuroBo Pharmaceuticals is oversold
- The Bollinger Bands (25) for NeuroBo Pharmaceuticals is (2.54 - 2.86), which suggest NeuroBo Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NeuroBo Pharmaceuticals is (2.83 - 4.27), which suggest NeuroBo Pharmaceuticals is a Sell
* NeuroBo Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.